# DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
> **ANDA212472** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2022-03-01
## Drug
- **FDA Application Number:** ANDA212472
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
- **Generic name:** Doxylamine Succinate
- **Active ingredients:** DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ACTAVIS LABS FL INC
- **First approval:** 2022-03-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212472)
---
*MORVS · CC0 1.0*